Piramal Pharma Limited Announces Results for Q1 FY27
Partially corroborated51MUMBAI, India, July 29, 2026 /PRNewswire/ — Piramal Pharma Limited (NSE: PPLPHARMA) (BSE: 543635), a leading global pharmaceutical, health and wellness company, today announced its standalone and consolidated results for the First Quarter (Q1) ended 30th June 2026. Consolidated Financial Highligh...
First seen · latest update · India · other
- Indian mainstream 0
- Indian independent 1
- International 0
- Official 0
See a mistake? Wrong summary · Wrongly grouped · Missing source · Wrong category/region · Dispute outlet rating — each opens a pre-filled report on GitHub.